Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Qudexy® XR (topiramate) – New indication
March 30, 2017 – Upsher-Smith announced the FDA approval of Qudexy XR (topiramate) extended-release capsules, for the prophylaxis of migraine headache in adults and adolescents 12 years of age and older.
